15 nəticələr
UNASSIGNED
To report on a severe case of presumed giant cell arteritis (GCA) presenting with partial and complete ophthalmic artery occlusion along with bilateral central retinal vein occlusions (CRVO).
UNASSIGNED
A 73-year-old female presented with bilateral complete vision loss of sudden onset.
OBJECTIVE
To report branch retinal vein occlusion and retinal hemorrhages associated with tsutsugamushi disease.
METHODS
Case report of a 60-year-old woman who complained of fever, chills, headache, lymphadenopathy, and blurred vision in the right eye following an insect bite to the lower right
BACKGROUND
Conventional risk factors for retinal vein occlusion (RVO) are well established through large epidemiological studies, but triggering factors remain poorly known.
METHODS
A prospective observational study through a questionnaire was completed between January and October 2009 by patients
OBJECTIVE
To describe a case of central retinal vein occlusion in a young patient presenting with symptomatic malignant hypertension because of Conn syndrome.
METHODS
Single interventional case report.
RESULTS
A 44-year-old man presented with a 1-day history of headache and vision loss in his right
We describe a moyamoya (MMD) patient with bilateral consecutive branch retinal vein occlusion (BRVO). The patient had a medical history of severe headache, cranial haemorrhage, bilateral supraclinoid carotid artery occlusion, and "puff of smoke" collaterals on cerebral angiography and an
Simultaneous bilateral central retinal vein occlusion (CRVO) is a rare presentation that warrants consideration of an underlying hyperviscosity state. Increased serum viscosity can lead to the hematologic emergency of leukostasis with resultant vascular obstruction and hypoxic tissue damage. The
OBJECTIVE
To describe the 15-year incidence of retinal vein occlusion (central retinal vein occlusion and branch retinal vein occlusion) and associated risk factors.
METHODS
A population-based study where branch retinal vein occlusion and central retinal vein occlusion were detected at baseline (n =
OBJECTIVE
This study presents the case history of a 58-year-old woman with a diagnosed spontaneous carotid-cavernous fistula on the left side and mild hypertension.
UNASSIGNED
Headache, double vision, proptosis, ptosis of the left upper lid, paresis of the left abducens nerve, conjunctival edema,
Objective: To evaluate the short term safety and potential therapeutic effect of allogenic adipose tissue-derived stromal/stem cells (ASCs) + cholecalciferol in patients with recent-onset T1D. Methods: Prospective, phase II, open trial, pilot study in which patients with recent onset
BACKGROUND
Suprachoroidal gas injection has been reported as a complication of pneumatic retinopexy, and the usefulness of B-scan ultrasonography has been reported. A case of suprachoroidal gas injection as a complication of pars plana vitrectomy confirmed by computed tomography (CT) is presented
A 60-year-old Asian man presented with left rubeotic glaucoma secondary to a central retinal vein occlusion. He was successfully treated with laser diode cyclophotocoagulation of the ciliary body. Nine months later he developed right progressive visual loss, headache, corneal oedema, anterior
Vascular endothelial growth factor (VEGF) is a protein that is upregulated as a result of capillary dropout, hypoxia, and local inflammation secondary to increased intraluminal venous pressure from retinal vein compression and other forms of vascular occlusion such as branch retinal vein occlusion
Sixteen previously treated (with only one prior regimen) patients with histologically proven metastatic or locally recurrent colorectal carcinoma were treated with recombinant tumor necrosis factor (rTNF) administered by 30-minute i.v. infusions twice daily for 5 consecutive days every other week
OBJECTIVE
To describe a rare clinical entity of intraosseous skull base arteriovenous fistula managed with transvenous fistula embolization.
METHODS
A 57-year-old woman presented with complaints of headache and episodic tinnitus with progressive left-sided visual deterioration. Cross-sectional
Patients with active rheumatoid arthritis (RA) despite treatment with biologic disease-modifying antirheumatic drug (bDMARD) therapy need treatment options.To evaluate the effects of filgotinib vs placebo on the signs and symptoms of RA in a